Latest article: https://www.fool.com/investing/2022/03/17/teladoc-is-down-but-not-out-heres-why/

Disclosure: 200 shares at $109/share

Teladoc $TDOC has certainly fallen from its pandemic-driven, sky-high valuation. The company is trading for roughly 1/3 its peak market cap. Although the company remains unprofitable, I have been averaging down slowly.

I think the concern over revenue growth is unwarranted. Company's do not grow at 80%+ forever. Teladoc no doubt got a boost from the pandemic, but I feel that Management's guidance of 25%-30% growth this year is still impressive.

My main concern revolves around cash flow. If $TDOC can continue trimming its losses, then I think it will gain more favor across Wall Street over time. The company is crushing its competition, namely $TLMD and $AMWL. Frankly, I view Teladoc's real competition as better capitalized tech companies that could enter healthcare if they wanted ($AMZN $GOOG)

Interestingly, Amazon has partnered with Teladoc, integrating its technology with Alexa. From an outside perspective, this looks like a vote of confidence from Amazon, but I don't want to lean on this partnership too heavily just yet.

Overall I think Teladoc has a lot of tailwinds that could propel future growth. I'll be keeping an eye on profitability and investing/selling as I assess future earnings.

Let me know what you think!